Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2018, Article ID 4378310, 4 pages
https://doi.org/10.1155/2018/4378310
Case Report

Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis

1Cancer Molecular Diagnostics, St. James’s Hospital, Dublin 8, Ireland
2Department of Haematology, St. James’s Hospital, Dublin 8, Ireland

Correspondence should be addressed to Stephen E. Langabeer; ei.semajts@reebagnals

Received 27 November 2017; Accepted 7 February 2018; Published 22 February 2018

Academic Editor: Sergio Storti

Copyright © 2018 Stephen E. Langabeer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Lee and M. O. Arcasoy, “The clinical and laboratory evaluation of the patient with erythrocytosis,” European Journal of Internal Medicine, vol. 26, no. 5, pp. 297–302, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Arber, A. Orazi, R. Hasserjian et al., “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia,” Blood, vol. 127, no. 20, pp. 2391–2405, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Bento, H. Almeida, T. M. Maia et al., “Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (where is/are the missing gene(s)?),” European Journal of Haematology, vol. 91, no. 4, pp. 361–368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Bertozzi, M. Ruggeri, I. Nichele, G. Biagetti, E. Cosi, and M. L. Randi, “Thrombotic and hemorrhagic complications in idiopathic erythrocytosis,” American Journal of Hematology, vol. 92, no. 11, pp. E639–E641, 2017. View at Publisher · View at Google Scholar
  5. M. F. McMullin, “Investigation and management of erythrocytosis,” Current Hematologic Malignancy Reports, vol. 11, no. 5, pp. 342–347, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Haslam, M. A. Catherwood, E. Dobbin, A. Sproul, S. E. Langabeer, and K. I. Mills, “Inter-laboratory evaluation of a next-generation sequencing panel for acute myeloid leukemia,” Molecular Diagnosis & Therapy, vol. 20, no. 5, pp. 457–461, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. Langabeer, K. Haslam, and C. M. Flynn, “Isolated erythrocytosis associated with a CALR mutation,” Blood Cells, Molecules & Diseases, vol. 66, pp. 6-7, 2017. View at Publisher · View at Google Scholar
  8. S. Schnittger, U. Bacher, W. Kern, M. Schröder, T. Haferlach, and C. Schoch, “Report on two novel nucleotide exchanges in the JAK2 pseudo-kinase domain: D620E and E627E,” Leukemia, vol. 20, no. 12, pp. 2195–2197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Grünebach, U. Bross-Bach, L. Kanz, and P. Brossart, “Detection of a new D620E mutation in addition to V617F in a patient with polycythemia vera,” Leukemia, vol. 20, no. 12, pp. 2210-2211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Bahar, K. Barton, and A. R. Kini, “The role of exon 13 G571S JAK2 mutation in myeloproliferative neoplasms,” Leukemia Research Reports, vol. 6, pp. 27-28, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Cleyrat, J. Jelinek, F. Girodon et al., “JAK2 mutation and disease phenotype: a double L611/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5,” Leukemia, vol. 34, no. 5, pp. 1069–1073, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. I. S. Tiong, D. A. Casolari, S. Moore et al., “Apparent JAK2-negative polycythaemia vera due to compound mutations in exon 14,” British Journal of Haematology, vol. 178, no. 2, pp. 333–336, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Kapralova, H. Horvathova, C. Pecquet et al., “Cooperation of germ line JAK2 mutations E845D and R1063H in hereditary erythrocytosis with megakaryocytic atypia,” Blood, vol. 128, no. 10, pp. 1418–1423, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. M. F. McMullin and H. Cario, “LNK mutations and myeloproliferative disorders,” American Journal of Hematology, vol. 91, no. 2, pp. 248–251, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Maslah, B. Cassinat, E. Verger, J. J. Kiladjian, and L. Velazquez, “The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders,” Leukemia, vol. 31, no. 8, pp. 1661–1670, 2017. View at Publisher · View at Google Scholar
  16. E. Lesteven, M. Picque, C. Conejero Tonetti et al., “Association of a single-nucleotide polymorphism in the SH2B3 gene with JAK2 V617F-positive myeloproliferative neoplasms,” Blood, vol. 123, no. 5, pp. 794–796, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. K. Christiansen, S. B. Larsen, M. Nyegaard et al., “The SH2B3 and KCNK5 loci may be implicated in regulation of platelet count, volume, and maturity,” Thrombosis Research, vol. 158, pp. 86–92, 2017. View at Publisher · View at Google Scholar
  18. D. F. Gudbjartsson, U. S. Bjomsdottir, E. Halapi et al., “Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction,” Nature Genetics, vol. 41, no. 3, pp. 342–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. E. Daly, “Determinants of platelet count in humans,” Haematologica, vol. 96, no. 1, pp. 10–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. K. Ganesh, N. A. Zakai, F. J. A. van Rooiij et al., “Multiple loci influence erythrocyte phenotypes in the CHARGE consortium,” Nature Genetics, vol. 41, no. 11, pp. 1191–1198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Chen, F. Fang, Y. Hu et al., “The polymorphisms in LNK gene correlated to the clinical type of myeloproliferative neoplasms,” PLoS One, vol. 11, no. 4, Article ID e0154183, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. D. A. Hinds, K. E. Barnholt, R. A. Mesa et al., “Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms,” Blood, vol. 128, no. 8, pp. 1121–1128, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. McMullin, C. Wu, M. J. Percy, and W. Tong, “A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis,” American Journal of Hematology, vol. 86, no. 11, pp. 962–964, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Cerquozzi and A. Tefferi, “Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors,” Blood Cancer Journal, vol. 5, no. 11, p. e366, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Labno-Kirszniok, T. Niesporek, A. Wiecek, G. Helbig, and J. Lubinski, “Acute myeloid leukemia in a 38-year-old hemodialyzed patient with von Hippel-Lindau disease,” Hereditary Cancer in Clinical Practice, vol. 11, no. 1, p. 11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Reindl, H. Quentmeier, K. Petropoulos et al., “CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes,” Clinical Cancer Research, vol. 15, no. 7, pp. 2238–2247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Camps, N. Petousi, C. Bento et al., “Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations,” Haematologica, vol. 101, no. 11, pp. 1306–1318, 2016. View at Publisher · View at Google Scholar · View at Scopus